John Oyler, BTX | GenomeWeb

John Oyler, BTX

Premium

People in the News

John Oyler has left RNAi startup Galenea as CEO, RNAi News has learned.

According to Pamela Esposito, who is in charge of business development and strategic planning at the company, Oyler left about a month ago to pursue another entrepreneurial opportunity.

She said that the company is "grateful to John for the two years he gave to Galenea."

She noted that Galenea is actively searching for a new CEO.

 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.